We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current AELIS market cap is 175M. The company's latest EPS is EUR -0.3830 and P/E is -34.46.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 1.69M | 1.32M | 10.76M | 8.36M | 12.36M |
| Operating Income | -2.99M | -2.84M | 2.55M | -8.53M | -6.46M |
| Net Income | -3.17M | -2.09M | 574k | -14.29M | -5.08M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 7.22M | 7M | 28.31M | 39.22M | 26.28M |
| Total Liabilities | 6.02M | 7.71M | 27.41M | 19.43M | 13.08M |
| Total Equity | 1.2M | -711k | 899k | 19.79M | 13.2M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -2.89M | -2.48M | 18.97M | -13.05M | -12.96M |
| Investing | -36k | -34k | -212k | -86k | -88k |
| Financing | 3.57M | 1.28M | 178k | 22.1M | -968k |
| Market Cap | 175M |
| Price to Earnings Ratio | -34.46 |
| Price to Sales Ratio | 14.16 |
| Price to Cash Ratio | 8.65 |
| Price to Book Ratio | 13.26 |
| Dividend Yield | - |
| Shares Outstanding | 13.26M |
| Average Volume (1 week) | 264 |
| Average Volume (1 Month) | 191 |
| 52 Week Change | -5.71% |
| 52 Week High | 14.00 |
| 52 Week Low | 12.80 |
| Spread (Intraday) | 0.2 (1.52%) |
| Company Name | Aelis Farma SA |
| Address |
1 rue lafaurie de monbadon bordeaux, gironde 33000 |
| Website | https://www.aelisfarma.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
